Award

Reue recognized as a ‘leader in the field of lipid and energy metabolism’

She won the ASBMb's 2015 Avanti Award In Lipids
Mark Stewart
By Mark Stewart
March 01, 2015

Karen Reue, professor and interim chair of human genetics and professor of medicine at the University of California, Los Angeles, won the Avanti Award in Lipids from the American Society for Biochemistry and Molecular Biology. The award recognizes Reue’s novel contributions to our understanding of lipid metabolism and homeostasis.

Karen-Reue-web.jpg "I am truly honored and excited to receive the Avanti award, which previously has been presented to some of my personal heroes in the field of lipid research. I acknowledge the many wonderful mentors, colleagues and trainees who have influenced my work over the years." — KAREN REUE

Reue’s scientific success is, in part, due to “her expertise in both mouse genetics, especially as applied to lipid metabolism, and molecular biology,” said Peter Edwards at the University of California, Los Angeles, who nominated Reue for the award.

Using naturally occurring mutations in mice and positional cloning, Reue identified the lipin gene family (lipin-1, lipin-2 and lipin-3). The three lipin proteins are phosphatidate phosphatases required for the conversion of phosphatidic acid to diacylglycerol. Reue’s work has demonstrated that lipin proteins play critical roles in adipogenesis and triacylglycerol storage, energy metabolism and insulin sensitivity in skeletal muscle, and lipid homeostasis in the aging brain. Recently, Reue’s laboratory identified a role for lipin-1 in autophagy, which may relate to the disease symptoms of lipin-1-deficient individuals.

“The lipin proteins are now studied in numerous laboratories in several countries, an indicator of the important biological role of the lipin proteins,” says Rudolf Zechner of the Institute of Molecular Biosciences in Graz, Austria.

Reue’s lab also identified an additional novel gene, Diet1, isolated from a mouse strain resistant to high blood-cholesterol levels. Inactivating mutations in Diet1 impair signaling from the intestine to the liver, resulting in excess cholesterol being converted to bile acids. These bile acids are secreted into the intestine and subsequently are excreted from the body. These metabolic changes prevent the accumulation of excess cholesterol in the blood.

Future work will explore the role of Diet1 genetic variants in human cholesterol homeostasis. It is hoped that such studies may explain why certain people are resistant to hypercholesterolemia. “The significance of Diet1 in physiology and its potential as a therapeutic target have been widely recognized,” says Stephen Young at the University of California, Los Angeles.

Alan Attie from the University of Wisconsin-Madison said Reue “thinks deeply about important questions in biology and finds elegant ways to study them.” Zechner added that “a hallmark of her research is the comprehensive nature of the studies.”

Reue earned her Ph.D. from the University of California, Los Angeles, after which she began her postdoctoral training at The Rockefeller University in New York. Reue returned to UCLA and rose through the ranks to professor. Reue’s work has been funded continuously by the National Institutes of Health.

Mark Stewart
Mark Stewart

Mark Stewart is a Ph.D. student in the University of Alabama at Birmingham’s cancer biology program and works in the pathology department.

Join the ASBMB Today mailing list

Sign up to get updates on articles, interviews and events.

Latest in People

People highlights or most popular articles

Understanding cellular function to understand life
ASBMB Annual Meeting

Understanding cellular function to understand life

March 05, 2021

Geoffrey Hesketh will speak during the Molecular & Cellular Proteomics early career researcher session on proximity-dependent biotinylation at the 2021 ASBMB Annual Meeting.

Finding a fulfilling scientific career in industry
Jobs

Finding a fulfilling scientific career in industry

March 05, 2021

Our industry careers columnist talked to Sadiye Amcaoglu Rieder, who has worked in biotech for more than five years and currently works at Viela Bio.

Become the protein
News

Become the protein

March 04, 2021

Biochemists and biophysicists represented the proteins they study through movement in this year’s "Dance your Ph.D." competition.

Decoding organ communication systems
ASBMB Annual Meeting

Decoding organ communication systems

March 04, 2021

Ilia Droujinine will speak during the Molecular & Cellular Proteomics presentation on biological insights revealed by proteomics at the 2021 ASBMB Annual Meeting.

Branon works to break barriers in science and higher education
ASBMB Annual Meeting

Branon works to break barriers in science and higher education

March 03, 2021

Tess Branon will speak on proximity-dependent biotinylation during the Molecular & Cellular Proteomics early-career researcher session at the 2021 ASBMB Annual Meeting.

A steady hand at the helm
Interview

A steady hand at the helm

March 02, 2021

The ASBMB’s new executive director, Steve Miller, is a society veteran but eager to make his mark.